Atezolizumab alone or in combination with bevacizumab for untreated metastatic kidney cancer
This paper reports patient-reported outcomes from the phase 2 IMmotion150 [...]
Cryoablation is safe and effective for small kidney tumours
A new study published in the American Journal of Roentgenology [...]
Positive results from trial of cabozantinib plus nivolumab combination in untreated metastatic kidney cancer
Results from the pivotal phase 3 CheckMate-9ER clinical trial evaluating [...]
Cabozantinib in combination with immunotherapy for advanced kidney cancer
In this video interview, Dr Monty Pal from the City [...]
Diagnostic biomarkers for rare subtype of kidney cancer
There are more than 10 different subtypes of renal cell [...]
Predictive factors for recurrence after complete metastasectomy in metastatic kidney cancer patients
In this retrospective study, published in Science Direct this month, [...]
Atezolizumab and bevacizumab for non-clear cell renal cell carcinoma
In this video interview from Practice Update, Dr Brad McGregor [...]
The impact of COVID-19 on kidney cancer patients: Survey findings
This video discussion brings together Professor Jamie Landman, urologist from [...]
First-line immunotherapy combination treatments for metastatic kidney cancer
A meta-analysis of four major clinical trials of immunotherapy combinations [...]
Individualised axitinib dosing for patients with metastatic kidney cancer
In the following video interview with Practice Update, Dr Nancy [...]
